Common Equity: The sum of all common equity items.
Medicenna Therapeutics Corp. (MDNAF) had Common Equity of $3.85M for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-18.88M |
|
-- |
|
-- |
|
$13.84M |
|
$-13.84M |
|
$-5.03M |
|
$-18.88M |
|
$-18.88M |
|
$-18.88M |
|
$-18.88M |
|
$-18.88M |
|
$-18.88M |
|
$-13.84M |
|
$-13.84M |
|
69.64M |
|
69.64M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$14.14M |
|
-- |
|
$0.04M |
|
$14.18M |
|
$2.12M |
|
-- |
|
$8.21M |
|
$10.34M |
|
|
Common Equity |
$3.85M |
$3.81M |
|
$3.85M |
|
69.64M |
|
| Cash Flow Statement Financials | |
$-12.05M |
|
-- |
|
-- |
|
$24.90M |
|
$12.59M |
|
$-12.32M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-490.58% |
|
-496.03% |
|
-133.09% |
|
-490.58% |
|
$0.06 |
|
$-0.17 |
|
$-0.17 |
|